Hanson & Doremus Investment Management’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
II
BFS
OFS
CW
PFG
PAW
Hanson & Doremus Investment Management's IBD Position: Q1 2026 in Review
Hanson & Doremus Investment Management reduced its Inspire Corporate Bond ETF (IBD) stake by 1.5% in Q1 2026, selling an estimated $2.41K and leaving 6,435 shares worth $154K. The position accounts for 0.02% of the portfolio, ranked #218.
Hanson & Doremus Investment Management first reported a position in IBD in Q3 2025 and has held it in 3 quarters since. The position peaked at $158K in Q4 2025. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.
- Hanson & Doremus Investment Management held 6,435 shares of Inspire Corporate Bond ETF worth $154K as of Q1 2026.
- Hanson & Doremus Investment Management sold 100 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $2.41K.
- Inspire Corporate Bond ETF made up 0.02% of Hanson & Doremus Investment Management's portfolio in Q1 2026, its #218 holding.
- Hanson & Doremus Investment Management first reported a position in Inspire Corporate Bond ETF in Q3 2025 and has held it in 3 quarters since.
- Hanson & Doremus Investment Management's Inspire Corporate Bond ETF position peaked at $158K in Q4 2025.
- 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q1 2026, filed 17 Apr 2026.